[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 8, Issue 2 And Suppl 1 (Int J Mol Cell Med (Suppl 1) 2019) ::
Int J Mol Cell Med 2019, 8(2 And Suppl 1): 0-0 Back to browse issues page
The Association Analysis of Vascular Endothelial Growth Factor -2549 Insertion/Deletion Variant and Endometriosis Risk
Negar Sarhangi1 , Shahrzad Mohseni2 , Soheila Aminimoghaddam3 , Batool Hossein Rashidi4 , Fedyeh Haghollahi3 , Mostafa Qorbani5 , Mahsa Mohammad Amoli6 , Maryam Shahrabi-Farahani 7
1- Personalized Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran; Metabolic Disorders Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
2- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
3- Department of Obstetrics and Gynecology, Iran University of Medical Sciences, Tehran, Iran.
4- Vali-e-Asr Reproductive Health Research Center, Tehran University of Medical Sciences, Tehran, Iran.
5- Department of Community Medicine, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran.
6- Metabolic Disorders Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
7- Metabolic Disorders Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. , maryam_shahrabif@yahoo.com
Abstract:   (148 Views)
Endometriosis is a debilitating disorder, defined as the presence of endometrial gland and stroma outside of the uterus. It may affect angiogenesis and vascular endothelial growth factor (VEGF) is one of the angiogenic factors that plays an important role in both physiological and pathological angiogenesis. The present study aimed to evaluate the association of VEGF -2549 insertion/deletion (I/D) polymorphism with endometriosis. This case-control study enrolled 244 (100 cases and 144 controls) women who were admitted for laparoscopy or laparotomy for gynecological procedures. Genomic DNA was separated from peripheral blood leukocytes and polymerase chain reaction amplification was performed for genotyping of the VEGF gene Insertion/Deletion (I/D) polymorphism. The frequency of the II, ID, and DD genotype was 14%, 52% and 34% in patients versus 18.8%, 47.8% and 34% in controls. The results did not provide any evidence supporting the endometriosis risk related to the VEGF polymorphism in Iranian women population.
Keywords: Endometriosis, vascular endothelial growth factor, VEGF, -2549 I/D, polymorphism
     
Type of Study: Original Article | Subject: Genetics & Disease
Received: 2019/03/13 | Accepted: 2019/05/20
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA code


XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sarhangi N, Mohseni S, Aminimoghaddam S, Hossein Rashidi B, Haghollahi F, Qorbani M, et al . The Association Analysis of Vascular Endothelial Growth Factor -2549 Insertion/Deletion Variant and Endometriosis Risk. Int J Mol Cell Med. 2019; 8 (2)
URL: http://ijmcmed.org/article-1-1045-en.html


Volume 8, Issue 2 And Suppl 1 (Int J Mol Cell Med (Suppl 1) 2019) Back to browse issues page
International Journal of Molecular and Cellular Medicine (IJMCM) International Journal of Molecular and Cellular Medicine (IJMCM)
Persian site map - English site map - Created in 0.05 seconds with 32 queries by YEKTAWEB 3897